Fig. 6
From: Establishment of a prognostic signature for lung adenocarcinoma using cuproptosis-related lncRNAs
Construction and validation of the nomogram. a 1-, 3-, and 5-year survival nomograms of LUAD patients with clinical indicators. b Calibration curves used to evaluate the prognostic signature predicting 1-, 3-, and 5-year survival rates in patients with LUAD. Dashed gray lines represent the ideal prediction models. c PCA of all genes. d PCA of cuproptosis-related genes. e PCA of cuproptosis-related lncRNAs. f PCA of risk lncRNAs